Mesenchymal stem cells are sensitive to treatment with kinase inhibitors and ionizing radiation

Effects of bone marrow or mesenchymal stem cell transplantation on oral mucositis (mouse) induced by fractionated irradiation

(2014) M. Schmidt et al.   STRAHLENTHERAPIE UND ONKOLOGIE

Application of organ tolerance dose-constraints in clinical studies in radiation oncology

(2014) Wolfgang Dörr et al.   STRAHLENTHERAPIE UND ONKOLOGIE

Imatinib Radiosensitizes Bladder Cancer by Targeting Homologous Recombination

(2013) B. Qiao et al.   CANCER RESEARCH

Mesenchymal Stem Cells Retain Their Defining Stem Cell Characteristics After Exposure to Ionizing Radiation

(2013) Nils H. Nicolay et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Gene-modified Mesenchymal Stem Cells Protect Against Radiation-induced Lung Injury

(2013) Jianxin Xue et al.   MOLECULAR THERAPY

Glycolysis-related gene induction and ATP reduction during fractionated irradiation

(2013) K. Goetze et al.   STRAHLENTHERAPIE UND ONKOLOGIE

Perspectives on mesenchymal stem cells: Tissue repair, immune modulation, and tumor homing

(2012) Hyun Sook Hong et al.   ARCHIVES OF PHARMACAL RESEARCH

Resistance of Glioblastoma-Initiating Cells to Radiation Mediated by the Tumor Microenvironment Can Be Abolished by Inhibiting Transforming Growth Factor-β

(2012) Matthew E. Hardee et al.   CANCER RESEARCH

LY2109761 Attenuates Radiation-Induced Pulmonary Murine Fibrosis via Reversal of TGF-  and BMP-Associated Proinflammatory and Proangiogenic Signals

(2012) P. Flechsig et al.   CLINICAL CANCER RESEARCH

Cediranib Plus FOLFOX/CAPOX Versus Placebo Plus FOLFOX/CAPOX in Patients With Previously Untreated Metastatic Colorectal Cancer: A Randomized, Double-Blind, Phase III Study (HORIZON II)

(2012) Paulo M. Hoff et al.   JOURNAL OF CLINICAL ONCOLOGY

Mechanisms of fibrosis: therapeutic translation for fibrotic disease

(2012) Thomas A Wynn et al.   NATURE MEDICINE

Evaluation of tyrosine receptor kinases in the interactions of head and neck squamous cell carcinoma cells and fibroblasts

(2012) Larissa Sweeny et al.   ORAL ONCOLOGY

Cytokines in Radiobiological Responses: A Review

(2012) Dörthe Schaue et al.   RADIATION RESEARCH

Blockade of TGF-  Signaling by the TGF R-I Kinase Inhibitor LY2109761 Enhances Radiation Response and Prolongs Survival in Glioblastoma

(2011) M. Zhang et al.   CANCER RESEARCH

Mesenchymal Stem Cells

(2011) Adam R. Williams et al.   CIRCULATION RESEARCH

TGF 1 Inhibition Increases the Radiosensitivity of Breast Cancer Cells In Vitro and Promotes Tumor Control by Radiation In Vivo

(2011) F. Bouquet et al.   CLINICAL CANCER RESEARCH

Imatinib inhibits proliferation of human mesenchymal stem cells and promotes early but not late osteoblast differentiation in vitro

(2011) Sofia Jönsson et al.   JOURNAL OF BONE AND MINERAL METABOLISM

Mesenchymal stem cell-based treatment for cartilage defects in osteoarthritis

(2011) Yiying Qi et al.   MOLECULAR BIOLOGY REPORTS

Efficacy of a Tyrosine Kinase Inhibitor in Idiopathic Pulmonary Fibrosis

(2011) Luca Richeldi et al.   NEW ENGLAND JOURNAL OF MEDICINE

The Tyrosine Kinase Inhibitor Dasatinib Induces a Marked Adipogenic Differentiation of Human Multipotent Mesenchymal Stromal Cells

(2011) Adriana Borriello et al.   PLoS One

Tomorrow's targeted therapies in breast cancer patients: What is the risk for increased radiation-induced cardiac toxicity?

(2010) Nicolas Magné et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival

(2009) James A Bonner et al.   LANCET ONCOLOGY

PDGF, TGF- , and FGF signaling is important for differentiation and growth of mesenchymal stem cells (MSCs): transcriptional profiling can identify markers and signaling pathways important in differentiation of MSCs into adipogenic, chondrogenic, and osteogenic lineages

(2008) F. Ng et al.   BLOOD

Combination of Vascular Endothelial Growth Factor Receptor/Platelet-Derived Growth Factor Receptor Inhibition Markedly Improves Radiation Tumor Therapy

(2008) C. Timke et al.   CLINICAL CANCER RESEARCH

Blocking transforming growth factor-beta up-regulates E-cadherin and reduces migration and invasion of hepatocellular carcinoma cells

(2008) Emilia Fransvea et al.   HEPATOLOGY

LY2109761, a novel transforming growth factor   receptor type I and type II dual inhibitor, as a therapeutic approach to suppressing pancreatic cancer metastasis

(2008) D. Melisi et al.   MOLECULAR CANCER THERAPEUTICS